Nektar Therapeutics
Oligomer-opioid agonist conjugates

Last updated:

Abstract:

The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Status:
Grant
Type:

Utility

Filling date:

19 Oct 2018

Issue date:

24 Dec 2019